Several other analysts have also issued reports on NBLX. Bank of America cut their price target on Noble Midstream Partners from $42.00 to $35.00 and set a “buy” rating for the company in a report on Tuesday, September 10th. Scotiabank started coverage on Noble Midstream Partners in a research report on Tuesday, September 3rd. They issued a “sector perform” rating and a $29.00 price target for the company. Noble Financial began coverage on Noble Midstream Partners in a research note on Tuesday, September 3rd. They issued a “sector perform” rating and a $29.00 price objective on the stock. Zacks Investment Research cut Noble Midstream Partners from a “buy” rating to a “hold” rating in a research report on Saturday, November 16th.
Finally, Credit Suisse Group downgraded Noble Midstream Partners from an “outperform” rating to a “hold” rating and cut their price objective for the company from $31.00 to $23.00 in a research note on Monday, November 25th. Seven research analysts have rated the stock with a hold rating, four have issued a buy rating and one has assigned a strong buy rating to the company. The stock currently has an average rating of “Buy” and an average target price of $33.36.
Successful Trading is the art of minimizing long term risk and maximizing capital allocation.
FEATURED Cannabix Technologies Launches New Compact Breath Logix Workplace Series and Prepares for Delivery to South Africa • May 7, 2024 8:51 AM
NanoViricides Reports that the Phase I NV-387 Clinical Trial is Completed Successfully and Data Lock is Expected Soon • NNVC • May 2, 2024 10:07 AM
ILUS Files Form 10-K and Provides Shareholder Update • ILUS • May 2, 2024 8:52 AM
Avant Technologies Names New CEO Following Acquisition of Healthcare Technology and Data Integration Firm • AVAI • May 2, 2024 8:00 AM
Bantec Engaged in a Letter of Intent to Acquire a Small New Jersey Based Manufacturing Company • BANT • May 1, 2024 10:00 AM
Cannabix Technologies to Deliver Breath Logix Alcohol Screening Device to Australia • BLO • Apr 30, 2024 8:53 AM